Scientists develop cross-species coronavirus test

Sarep­ta and Roche’s con­fir­ma­to­ry study for a Duchenne gene ther­a­py failed to hit its pri­ma­ry end­point, com­pli­cat­ing plans to con­vert the drug’s la­bel in­to a

Sen. Eliz­a­beth War­ren (D-MA) has put the spot­light on No­vo Hold­ings’ ac­qui­si­tion of Catal­ent, ex­press­ing con­cerns that the deal could give No­vo Nordisk “un­prece­dent­ed vis­i­bil­i­ty”